Hopkins Research Team Cultures Long-Awaited Human Embryonic Stem Cells

November 06, 1998

"The potential of these unique, versatile cells for human biologic studies and medicine is enormous"

A team of scientists has isolated and identified human stem cells and proved them capable of forming the fundamental tissues that give rise to distinct human cells such as muscle, bone and nerve. This feat has for decades been one of basic science's holy grails, and while scientists have found stem cells in mice and higher animals, this is believed to be the first time researchers have cultured human embryonic stem cells.

"The potential of these unique, versatile cells for human biologic studies and medicine is enormous," says John Gearhart, Ph.D., a professor of obstetrics/gynecology and of physiology who led the mostly Johns Hopkins research team. "These cells will rapidly let us study human processes in a way we couldn't before. Instead of having to rely on mice or other substitutes for human tissues, we'll have a unique resource that we can start applying to medicine."

The Hopkins research is reported in this month's Proceedings of the National Academy of Sciences. A related success, but one reached by a different path, is described by a University of Wisconsin team in a study in this week's Science. (The Science issue includes a commentary by Gearhart.)

The key to stem cells' importance rests in their lack of specialization. They're basic cells present in the earliest stages of developing embryos. They spark all the types of cells in a developing organism, while they themselves keep the ability to reproduce continuously.

"Not only should scientists be able to generate specific nerve, muscle, skin or other cells for transplantation, but we should also be able to alter these cells, as has been done in mouse studies, to reduce the likelihood of rejection. We could make universal donors. More specific cells could become transplant therapies for diabetes, spinal cord injury, neurodegenerative disorders like Parkinson's disease, muscular dystrophies, atherosclerosis and wound healing," says Gearhart. Stem cells could prove valuable in studies on birth defects, pregnancy loss and cancer biology by revealing which genes play a role, using a system that's uniquely human and easy to study.

In the Hopkins research, the scientists searched small samples of non-living, human fetal tissue to find what they call primordial germ cells (PGC) cells that eventually would have become eggs and sperm. The single PGCs were placed on a "feeder layer" of mouse connective tissue cells, surrounded by a broth of nutrients and highly specialized growth factors. That provided support and other requirements for the PGCs to develop. "Hitting just the right elements to culture these cells was no simple matter," says Michael Shamblott, Ph.D., a researcher on the project. "We built on earlier mouse studies, trying to do just enough to let the cells develop without going too far and becoming specialized."

Under the right conditions, PGCs develop into a tightly knit cluster of true stem cells. These "pluripotent stem cells," as they're called, met a stem cell ID checklist as part of the study: They displayed various cell surface markers characteristic of stem cells, contained complete sets of normal chromosomes and produced enzymes typical of stem cells. The cells are also capable of many cell divisions.

"But the gold standard," says Shamblott, "was seeing if the cells have true potential if they'd develop into the three basic layers of cells found in all mammalian embryos. And ours did." The pluripotent stem cells sporadically gave rise to small, eighth-inch knots of slightly more advanced tissue. Immunochemical and other tests confirmed that the three layers were there.

"Stem cells aren't useful by themselves," says Shamblott. Their most immediate value, he says, will likely come in the form of tissues clinicians can transplant therapeutically to replace diseased or dying cells. The first step for that, Shamblott says, is learning how to spark the next level of stem cells those with a more narrow mission. Such "lineage restricted stem cells" trigger blood formation, for example. Another line would generate muscle cells.

Other researchers in the study were John Littlefield, M.D., Paul Blumenthal, M.D., and George Huggins, M.D. Peter Donovan of the Kimmel Cancer Institute, Jefferson Medical College in Philadelphia also was on the research team.

Geron, Inc., of Menlo Park, Calif., provided funding for the study described in this release. Under a licensing agreement between Geron and the Johns Hopkins University, Dr. Gearhart is entitled to a share of sales royalty received by the University from sales of the technology described in this release. Both the University and Dr. Gearhart own stock in Geron, the sale of which is subject to certain restrictions under University policy. Dr. Gearhart is also a consultant to Geron. The terms of this arrangement are being managed by the University in accordance with its conflict of interest policies.
-end-
Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on at EurekAlert , Newswise and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at Johns Hopkins Medical Institutions, Quadnet and ScienceDaily.



Johns Hopkins Medicine

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.